Wendy Stock

30PUBLICATIONS
242CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Sep 16, 2026
Outcomes by Body Mass Index in Patients With B-Cell Precursor Acute Lymphoblastic Leukemia Treated with Inotuzumab Ozogamicin.

|Jun 15, 2026
Prognostic and therapeutic implications of BRAF mutations in acute myeloid leukemia.

|Apr 17, 2026
Genomic Subtype Influences BH3 Mimetic Drug Sensitivity and Synergy with Cytotoxic Chemotherapeutics in T-cell Acute Lymphoblastic Leukemia.

|Mar 04, 2026
Targeting Menin in T-lineage Acute Lymphoblastic Leukemia.

Kathryn Shimamoto, Diren Arda Karaoglu, Olivia Arnold

|Sep 30, 2025
Inotuzumab Ozogamicin Then Blinatumomab for Older Adults With Newly Diagnosed B-Cell ALL: Alliance Study A041703 Cohort 1 Results.

Matthew J Wieduwilt, Jun Yin, Oudom Kour

|Aug 14, 2025
Clinical and molecular characterization of TP53-mutant acute lymphoblastic leukemia in adults.

Ethan J Harris, Diren Arda Karaoglu, Madina Sukhanova

Pageof 5

Frequent Collaborators

7 joint publications

Adam S DuVall

7 joint publications

Anand Ashwin Patel

6 joint publications

Caner Saygin

5 joint publications

Geoffrey L Uy